I
IRX
vs
S
S&P/ASX 300
Over the past 12 months, IRX has outperformed S&P/ASX 300, delivering a return of +9% compared to the S&P/ASX 300's +3% growth.
Stocks Performance
IRX vs S&P/ASX 300
Performance Gap
IRX vs S&P/ASX 300
Performance By Year
IRX vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Inhalerx Ltd
Glance View
InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.
